Spero Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2021-07-14. The offering totals $40.0M, of which $40.0M was reported sold. Industry: Biotechnology.
Showing 25 of 26 people.
| Name | Role | Location |
|---|---|---|
| Jean-Francois Formela | Director | Cambridge, MA |
| Scott Jackson | Director | Columbia, MD |
| Patrick C Vink | Director | Cambridge, MA |
| Tamara E Joseph | Executive Officer | Cambridge, MA |
| Timothy E Keutzer | Executive Officer | Cambridge, MA |
| Cristina E Larkin | Executive Officer | Cambridge, MA |
| David E Melnick | Executive Officer | Cambridge, MA |
| Satyavrat E Shukla | Executive Officer | Cambridge, MA |
| Casper Breum | Director | NESS ZIONA, L3 |
| Frank E Thomas | Director | LONDON, X0 |
| MILIND DESHPANDE | Director | WALTHAM, MA |
| Kamal C Hamed | Executive Officer | Cambridge, MA |
| Scott C Jackson | Director | Cambridge, MA |
| Tamara C Joseph | Executive Officer | Cambridge, MA |
| Kathleen C Tregoning | Director | Cambridge, MA |
| Patrick E Vink | Director | Cambridge, MA |
| Satyavrat Shukla | Executive Officer | Cambridge, MA |
| Timothy C Keutzer | Executive Officer | Cambridge, MA |
| John C Pottage, Jr. | Director | Cambridge, MA |
| Ankit Mahadevia | Director | Cambridge, MA |
| Ankit Mahadevia | Executive Officer | Cambridge, MA |
| Cynthia C Smith | Director | Cambridge, MA |
| Reza Halse | Director | Somerville, MA |
| Vikas Goyal | Director | Boston, MA |
| Patrick Vink | Director | Cambridge, MA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2022-11-15 | D | $9.0M | $9.0M |
| 2017-03-21 | D | $43.2M | $43.2M |